Nivata IPO Market Data
TNA Solutions
IPO GMP & Details
Check TNA Solutions IPO GMP and its recorded history, price band, issue dates, total subscription, lot size and listing date. Unofficial GMP is not a listing forecast.
At a glance
TNA Solutions IPO details
Unofficial market context
TNA Solutions IPO GMP trend
The chart shows recent GMP movement over time. GMP is unofficial and should not be treated as a listing-price forecast or recommendation.
Latest chart observation+₹6
Change across recorded history−₹4
Recorded observations3
Current GMP reference price₹73
+₹10+₹6
1 Oct2 Oct
| Observation | GMP | Change | Reference price |
|---|---|---|---|
| 2 Oct 2026, 5:25 AM | +₹6 | ₹0 | ₹76 |
| 1 Oct 2026, 2:32 PM | +₹6 | −₹4 | ₹76 |
| 1 Oct 2026, 1:44 PM | +₹10 | — | ₹80 |
Issue schedule & market details
TNA Solutions IPO key data
These are structured market-data fields. Missing values are left blank rather than estimated.
Issue typeSME
Price band₹66 – ₹70
Issue price₹70
Lot size2,000 shares
Issue size₹37.86 Cr
Open date30 Sep 2026
Close date6 Oct 2026
Listing date9 Oct 2026
Overall subscription51.39× subscribed
Last recorded GMP+₹3
GMP reference price₹73
Quick facts
TNA Solutions IPO FAQs
When does the TNA Solutions IPO open and close?
The opening date is 30 Sep 2026. The closing date is 6 Oct 2026.
When is the TNA Solutions IPO listing date?
The currently recorded listing date is 9 Oct 2026. The timetable can change if the issue schedule is revised.
What is the TNA Solutions IPO price band?
The currently recorded price band is ₹66 – ₹70.
What is the TNA Solutions IPO GMP?
The latest GMP recorded by Nivata is +₹3. GMP is unofficial market information and is not a listing-price forecast.
What is the TNA Solutions IPO lot size?
The recorded lot size is 2,000 shares. Review the official issue terms before applying.
What is the TNA Solutions IPO subscription?
Nivata currently records overall issue subscription at 51.39 times. This is not an allotment probability.
This page contains factual IPO schedule, pricing, subscription, listing and GMP information. It does not contain an IPO research article and does not provide a recommendation, rating, target price, valuation conclusion, expected return, listing forecast, allotment probability or a view on whether to participate in the issue.